College of Food Science and Engineering, Ocean University of China, Qingdao, China.
College of Food Science and Engineering, Ocean University of China, Qingdao, China.
Nutrition. 2021 Apr;84:111112. doi: 10.1016/j.nut.2020.111112. Epub 2020 Dec 13.
Various probiotics and natural products can help to relieve constipation. This study aimed to explore the constipation-relieving effects and potential mechanism of a combination laxative of konjac glucomannan and probiotics.
This study evaluated the gastrointestinal-tract viability of probiotics in vitro. A constipation model was constructed in BALB/c mice, and the efficacies of the combinations verified in terms of their bowel movement-promoting effects, including the first black-stool defecation time and gastrointestinal transit rates of mice. Colonization by the probiotics was determined by quantitative real-time polymerase chain reaction. Hematoxylin-eosin staining, gas chromatography, enzyme-linked immunosorbent assay, quantitative real-time polymerase chain reaction, and Western blot were also used for analysis.
Lactobacillus paracasei X11 (X11) and L. casei YRL577 (YRL577) had outstanding gastrointestinal-tract viability. Konjac glucomannan (KGM) + X11, Prunus persica + X11, and Prunus persica + YRL577 significantly relieved constipation. In addition, KGM promoted the colonization of X11. Meanwhile, KGM + X11 effectively promoted the metabolism of short-chain fatty acids in mice better than other combinations, and the 5-hydroxytryptamine (5-HT) content in the KGM + X11 group was the highest among all the groups. Therefore, KGM + X11 was selected for further research. The combination laxative promoted the secretion of 5-HT, up-regulated mRNA and protein levels of 5-HT receptor 4 and serotonin transporter via the 5-HT pathway, and effectively relieved constipation.
The combination laxative konjac glucomannan-probiotic (KGM + X11) promoted defecation in constipated mice, possibly by increasing short-chain fatty acid metabolism and 5-HT hormone release.
各种益生菌和天然产物有助于缓解便秘。本研究旨在探索魔芋葡甘聚糖和益生菌联合泻药的通便作用及其潜在机制。
本研究评估了益生菌在体外的肠道存活能力。构建 BALB/c 小鼠便秘模型,验证组合药物的促肠蠕动作用,包括首次排黑便时间和小鼠胃肠道转运率。采用实时定量聚合酶链反应(qPCR)检测益生菌的定植情况。采用苏木精-伊红(HE)染色、气相色谱、酶联免疫吸附试验(ELISA)、qPCR 和 Western blot 进行分析。
副干酪乳杆菌 X11(X11)和干酪乳杆菌 YRL577(YRL577)具有出色的肠道存活能力。魔芋葡甘聚糖(KGM)+X11、桃仁+X11 和桃仁+YRL577 可显著缓解便秘。此外,KGM 促进了 X11 的定植。同时,KGM+X11 比其他组合更有效地促进了小鼠短链脂肪酸的代谢,并且 KGM+X11 组的 5-羟色胺(5-HT)含量在所有组中最高。因此,选择 KGM+X11 进行进一步研究。联合泻剂通过 5-HT 通路促进 5-HT 的分泌,上调 5-HT 受体 4 和血清素转运体的 mRNA 和蛋白水平,有效缓解便秘。
魔芋葡甘聚糖-益生菌联合泻剂(KGM+X11)促进了便秘小鼠的排便,可能是通过增加短链脂肪酸代谢和 5-HT 激素释放。